San Diego-based mostly Viking Therapeutics marked alone as a serious competitor within the weight loss drug marketplace in February after revealing promising facts from the mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection As well as in March th